Literature DB >> 23002246

Matrix-bound heparan sulfate is essential for the growth and pluripotency of human embryonic stem cells.

Mariana P Stelling1, Yury M V Lages, Ana M F Tovar, Paulo A S Mourão, Stevens K Rehen.   

Abstract

Human embryonic stem (hES) cell production of heparan sulfate influences cell fate and pluripotency. Human ES cells remain pluripotent in vitro through the action of growth factors signaling, and the activity of these factors depends on interaction with specific receptors and also with heparan sulfate. Here, we tested the hypothesis that matrix-associated heparan sulfate is enough to maintain hES cells under low fibroblast growth factor-2 concentration in the absence of live feeder cells. To pursue this goal, we compared hES cells cultured either on coated plates containing live murine embryonic fibroblasts (MEFs) or on a matrix derived from ethanol-fixed MEFs. hES cells were analyzed for the expression of pluripotency markers and the ability to form embryoid bodies. hES cells cultured either on live mouse fibroblasts or onto a matrix derived from fixed fibroblasts expressed similar levels of Oct-4, SOX-2, Nanog, TRA-1-60 and SSEA-4, and they were also able to form cavitated embryoid bodies. Heparan sulfate-depleted matrix lost the ability to support the adherence and growth of hES cells, confirming that this glycosaminoglycan, bound to the extracellular matrix, is enough for the growth and attachment of hES cells. Finally, we observed that the ethanol-fixed matrix decreases by 30% the levels of Neu5Gc in hES cells, indicating that this procedure reduces xeno-contamination. Our data suggest that matrix-bound heparan sulfate is required for the growth and pluripotency of hES cells and that ethanol-fixed MEFs may be used as a "live cell"-free substrate for stem cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23002246     DOI: 10.1093/glycob/cws133

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  7 in total

1.  Expression of stage-specific embryonic antigen-4 (SSEA-4) defines spontaneous loss of epithelial phenotype in human solid tumor cells.

Authors:  Kavitha Sivasubramaniyan; Abhishek Harichandan; Karin Schilbach; Andreas F Mack; Jens Bedke; Arnulf Stenzl; Lothar Kanz; Gerhard Niederfellner; Hans-Jörg Bühring
Journal:  Glycobiology       Date:  2015-05-15       Impact factor: 4.313

Review 2.  Mechanobiology: a new frontier for human pluripotent stem cells.

Authors:  Yubing Sun; Jianping Fu
Journal:  Integr Biol (Camb)       Date:  2013-03       Impact factor: 2.192

3.  Ethanol Inactivated Mouse Embryonic Fibroblasts Maintain the Self-Renew and Proliferation of Human Embryonic Stem Cells.

Authors:  Boxian Huang; Song Ning; Lili Zhuang; Chunyan Jiang; Yugui Cui; Guoping Fan; Lianju Qin; Jiayin Liu
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

4.  Network based meta-analysis prediction of microenvironmental relays involved in stemness of human embryonic stem cells.

Authors:  Virginie Mournetas; Quentin M Nunes; Patricia A Murray; Christopher M Sanderson; David G Fernig
Journal:  PeerJ       Date:  2014-10-23       Impact factor: 2.984

5.  Mitomycin-treated undifferentiated embryonic stem cells as a safe and effective therapeutic strategy in a mouse model of Parkinson's disease.

Authors:  Mariana Acquarone; Thiago M de Melo; Fernanda Meireles; Jordano Brito-Moreira; Gabriel Oliveira; Sergio T Ferreira; Newton G Castro; Fernanda Tovar-Moll; Jean-Christophe Houzel; Stevens K Rehen
Journal:  Front Cell Neurosci       Date:  2015-04-08       Impact factor: 5.505

6.  Development of a xeno-free substrate for human embryonic stem cell growth.

Authors:  Hailin Zhu; Jinliang Yang; Yuquan Wei; Harry Huimin Chen
Journal:  Stem Cells Int       Date:  2015-03-16       Impact factor: 5.443

Review 7.  Heparan Sulfate Proteoglycans: Key Mediators of Stem Cell Function.

Authors:  Maanasa Ravikumar; Raymond Alexander Alfred Smith; Victor Nurcombe; Simon M Cool
Journal:  Front Cell Dev Biol       Date:  2020-11-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.